<DOC>
	<DOC>NCT01193920</DOC>
	<brief_summary>This study will evaluate the safety and immunogenicity of a Group B Streptococcus vaccine at one dose in healthy non pregnant women and then in three different doses in healthy pregnant women.</brief_summary>
	<brief_title>Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age</brief_title>
	<detailed_description />
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Group 1 (Non Pregnant Women): Healthy females 1840 years of age inclusive. Group 2 (Healthy Pregnant Women): Healthy pregnant women 1840 yrs of age (between 2835 weeks gestation) Group 1 (Non Pregnant Women): Pregnant or nursing; History of severe allergy to previous vaccines; Known HIV positive Group 2 (Healthy Pregnant Women): History of severe allergy to previous vaccines; Known HIV positive</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Group B streptococcus</keyword>
	<keyword>GBS</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Prevention of group B streptococcus infection</keyword>
</DOC>